Evidence on the Benefits of Probiotics for Preterm Infants

Main Article Content

Campos-Martinez AM Fernández-Marín E Ruiz-López A Cubero-Millan I Gonzalez-Bolivar M Uberos J

Abstract

This article reviews the evidence for the use of different strains of probiotics in the prevention of prevalent pathologies in premature infants.


A systematic review was conducted of the use of probiotics in neonates with less than 37 weeks’ gestational age, based on a search for systematic reviews and observational and experimental studies performed during the period January 2014 to February 2021. For this purpose, the PubMed, MEDLINE and Cochrane Library databases were consulted. The aim of this article was to review the existing data on the relationship between the administration of probiotics (with different strains and doses) and the risk of necrotising enterocolitis (NEC), mortality, late sepsis and other disease parameters in premature infants.


The literature search obtained 240 articles, of which we selected 16, representing a total sample of over 200,000 premature infants. Analysis of the data obtained reveals statistical evidence that the combined administration of probiotics (especially Lactobacillus and Bifidobacterium strains) reduces the incidence of grade II or higher NEC, all-cause mortality, late sepsis, length of hospital stay and time until complete enteral nutrition is achieved. However, no benefits were apparent with respect to alleviating bronchopulmonary dysplasia, retinopathy of prematurity or intraventricular haemorrhage.


Further research is needed to determine the most appropriate strains, doses and treatment time for preterm infants to achieve the health benefits identified.

Article Details

How to Cite
AM, Campos-Martinez et al. Evidence on the Benefits of Probiotics for Preterm Infants. Medical Research Archives, [S.l.], v. 10, n. 1, jan. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/2642>. Date accessed: 28 nov. 2022. doi: https://doi.org/10.18103/mra.v10i1.2642.
Section
Review Articles

References

1. Hill C et al. “Expert consensus document: The international scientific association for probiotics and Gastroenterol prebiotics consensus statement on the scope and appropriate use of the term probiotic,” Nat. Rev.. Hepatol., vol. 11, no. 8, pp. 506–514, 2014, doi: 10.1038/nrgastro.2014.66.
2. Narbona López E, Uberos Fernández J, Armadá Maresca MI, Couce Pico ML, Rodríguez Martínez G, Saenz De Pipaon M. “Grupo de Nutrición y Metabolismo Neonatal, Sociedad Española de Neonatología: recomendaciones y evidencias para la suplementación dietética con probióticos en recién nacidos de muy bajo peso al nacer,” An. Pediatr., vol. 81, no. 6, pp. 397.e1-397.e8, 2014, doi: 10.1016/j.anpedi.2014.06.020.
3. Van Den Akker CHP et al. “Probiotics for preterm infants: a strain-specific systematic review and network meta-analysis,” J. Pediatr. Gastroenterol. Nutr., vol. 67, no. 1, pp. 103–122, 2018, doi: 10.1097/MPG.0000000000001897.
4. Chi C, Li, C, Buys N, Wang W, Yin C, Sun J. “Effects of probiotics in preterm infants: A network meta-analysis,” Pediatrics, vol. 147, no. 1, 2021, doi: 10.1542/PEDS.2020-0706.
5. Bi LW, Yan BL, Yang QY, Li MM, Cui HL, Couce ML. “Which is the best probiotic treatment strategy to prevent the necrotizing enterocolitis in premature infants: A network meta-analysis revealing the efficacy and safety,” Med. (United States), vol. 98, no. 41, pp. 1–13, 2019, doi: 10.1097/MD.0000000000017521.
6. Jin YT, Duan Y, Deng XK, Lin J. “Prevention of necrotizing enterocolitis in premature infants – an updated review,” World J. Clin. Pediatr., vol. 8, no. 2, pp. 23–32, 2019, doi: 10.5409/wjcp.v8.i2.23.
7. Baldassarre ME et al. “Dysbiosis and prematurity: Is there a role for probiotics?,” Nutrients, vol. 11, no. 6, 2019, doi: 10.3390/nu11061273.
8. Robertson C et al. “Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics,” Arch. Dis. Child. Fetal Neonatal Ed., vol. 105, no. 4, pp. 380–386, 2020, doi: 10.1136/archdischild-2019-317346.
9. Underwood MA. “Probiotics and the prevention of necrotizing enterocolitis,” J. Pediatr. Surg., vol. 54, no. 3, pp. 405–412, 2019, doi: 10.1016/j.jpedsurg.2018.08.055.
10. Xiong T, Maheshwari A, Neu J, Ei-Saie A, Pammi M. “An overview of systematic reviews of randomized-controlled trials for preventing necrotizing enterocolitis in preterm infants,” Neonatology, vol. 117, no. 1, pp. 46–56, 2020, doi: 10.1159/000504371.
11. Bi L, Yan B, Yang Q, Li M, Cui H. “Probiotic strategies to prevent necrotizing enterocolitis in preterm infants: a meta-analysis,” Pediatr. Surg. Int., vol. 35, no. 10, pp. 1143–1162, 2019, doi: 10.1007/s00383-019-04547-5.
12. Sun J, Marwah G, Westgarth M, Buys N, Ellwood D, Gray PH. “Effects of probiotics on necrotizing enterocolitis, sepsis, intraventricular hemorrhage, mortality, length of hospital stay, and weight gain in very preterm infants: A meta-analysis,” Adv. Nutr., vol. 8, no. 5, pp. 749–763, 2017, doi: 10.3945/an.116.014605.
13. Morgan RL et al. “Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials,” Gastroenterology, vol. 159, no. 2, pp. 467–480, 2020, doi: 10.1053/j.gastro.2020.05.096.
14. Aceti A et al. “Probiotics prevent late-onset sepsis in human milk-fed, very low birth weight preterm infants: Systematic review and meta-analysis,” Nutrients, vol. 9, no. 8, pp. 1–21, 2017, doi: 10.3390/nu9080904.
15. Dermyshi E et al. “The ‘golden age’ of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants,” Neonatology, vol. 112, no. 1, pp. 9–23, 2017, doi: 10.1159/000454668.
16. Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. “Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants,” Cochrane Database Syst. Rev., vol. 2020, no. 10, 2020, doi: 10.1002/14651858.CD005496.pub5.
17. Grev J, Berg M, and Soll R. “Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants,” Cochrane Database Syst. Rev., vol. 2018, no. 12, 2018, doi: 10.1002/14651858.CD012519.pub2.
18. Uberos J, Aguilera-Rodríguez E, Jerez-Calero A, Molina-Oya M, Molina-Carballo A, Narbona-López E. “Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants,” Br. J. Nutr., vol. 117, no. 7, pp. 994–1000, 2017, doi: 10.1017/S0007114517000769.
19. Plaza-Díaz J, Fontana L, and Gil A. “Human milk oligosaccharides and immune system development,” Nutrients, vol. 10, no. 8, 2018, doi: 10.3390/nu10081038.
20. Wisgrill L, Wessely I, Spittler A, Förster-Waldl E, Berger A, Sadeghi K. “Human lactoferrin attenuates the proinflammatory response of neonatal monocyte-derived macrophages,” Clin. Exp. Immunol., vol. 192, no. 3, pp. 315–324, 2018, doi: 10.1111/cei.13108.
21. Cormack BE, Harding JE, Miller SP, Bloomfield FH. “The influence of early nutrition on brain growth and neurodevelopment in extremely preterm babies: A narrative review,” Nutrients, vol. 11, no. 9, 2019, doi: 10.3390/nu11092029.